PubMed Health⌕ Search

Biomedical subjects

Y Z Qiu

Publications and source records attributed to Y Z Qiu.

3 recordsLinked to original sources

Surface modification using photocrosslinkable chitosan for improving hemocompatibility.

Immobilization of the anticoagulative or antithrombogenic biomolecule has been considered as one of the important methods to improve the blood compatibility of artificial biomaterials. In this study, a novel immobilization reaction scheme was utilized to incorporate O-butyrylchitosan (OBCS) onto the activated glass surface with an aim to develop an anticoagulative substrate. Activation of the glass surface was carried out by silanization and then OBCS was grafted to the silanized surface via a radiation grafting technique. The OBCS-grafted glass surfaces were characterized by electron spectroscopy for chemical analysis (ESCA) and atomic force microscopy (AFM). The blood compatibility of the OBCS-grafted glass was evaluated by platelet rich plasma (PRP) contacting experiments and protein adsorption experiments in vitro. These results have demonstrated that the surface with immobilized OBCS shows much less platelet adhesive and fibrinogen adsorption compared to the control surface. Therefore, the novel reaction scheme proposed here is very promising for future development of an anticoagulative glass substrate.

Blood Coagulation↗

[A nasopharyngeal carcinoma negatively related EST on 7q32].

To isolate and clone the tumor suppressor gene on chromosomal region 7q32 that corelated with the occurrence of human NPC, we detected the genotype of polymorphic microsatellite markers on 7q32 in 24 nasopharyngeal carcinoma biopsies and matched normal lymphocyte DNA. LOH was found in 30% biopsies. Using differential RT-PCR and Northern hybridization we compared the expression level of 20 EST on 7q32 between NPC cell line HNE1 and primary culture of normal nasopharyngeal epithelial cell, and found AA070437 EST expressed high in primary culture of normal nasopharyngeal epithelial cell, but very low in HNE1. Differential RT-PCR (dRT-PCR) analysis showed that the expression level of AA070437 was lower in 30.7% NPC biopses than in normal cell. Differential PCR (dPCR) showed that allelic loss of AA070437 was observed in 29.1% NPC biopses. This EST is a part of sequence of a new gene compared with GeneBank database. Our results showed that AA070437 EST negatively related with the occurrence of human NPC is a candidate of tumor suppressor gene of NPC on 7q32.

Base Sequence↗